Aktis Oncology, Inc. (AKTS) — Financial statements
Income statement, balance sheet, and cash flow for Aktis Oncology, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue & Gross Profit | |||||
| Revenue | 6↑336.9% | 1 | 0.00 | 0.00 | |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | 6↑336.9% | 1 | 0.00 | 0.00 | |
| Operating Expenses | |||||
| R&D Expenses | 67↑64.7% | 41↑58.0% | 26↑81.2% | 14 | |
| General & Administrative Expenses | 13↑11.4% | 11↑47.2% | 8↑50.4% | 5 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 13↑11.4% | 11↑47.2% | 8↑50.4% | 5 | |
| Other Expenses | 1↓11.3% | 1↑6.7% | 1↑236.0% | 0.36 | |
| Operating Expenses | 81↑51.6% | 54↑53.9% | 35↑76.0% | 20 | |
| Total Costs & Expenses | 81↑51.6% | 54↑53.9% | 35↑76.0% | 20 | |
| Operating Results | |||||
| Operating Income | -75↓43.5% | -52↓49.6% | -35↓76.0% | -20 | |
| Depreciation & Amortization | 2↑47.9% | 2↑31.7% | 1↑168.8% | 0.45 | |
| EBITDA | -72↓43.3% | -50↓50.2% | -34↓73.9% | -19 | |
| EBIT | -75↓43.5% | -52↓49.6% | -35↓76.0% | -20 | |
| Interest & Other Income | |||||
| Net Interest Income | 11↑35.9% | 8↑50.7% | 5↑226.5% | 2 | |
| Interest Income | 11↑35.9% | 8↑50.7% | 5↑226.5% | 2 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Income / Expenses | 11↑35.7% | 8↑31.2% | 6↑235.3% | 2 | |
| Income Before Tax | -64↓44.9% | -44↓53.6% | -29↓59.7% | -18 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | |||||
| Net Income from Continuing Operations | -64↓44.9% | -44↓53.6% | -29↓59.7% | -18 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -64↓44.9% | -44↓53.6% | -29↓59.7% | -18 | |
| Bottom-Line Net Income | -64↓44.9% | -44↓53.6% | -29↓59.7% | -18 | |
| EPS (Basic) | -1.19↑5.6% | -1.26↓53.7% | -0.82↓60.8% | -0.51 | |
| EPS (Diluted) | -1.19↑5.6% | -1.26↓53.7% | -0.82↓60.8% | -0.51 | |
| Weighted Average Shares | 53↑50.6% | 35↑0.0% | 35↑0.0% | 35 | |
| Weighted Average Diluted Shares | 53↑50.6% | 35↑0.0% | 35↑0.0% | 35 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.